# bendamustine hydrochloride

NDC: 16729-250
Generic name: bendamustine hydrochloride
Labeler / Manufacturer: Accord Healthcare, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20221207

FDA application: ANDA205574

## Active ingredients

- BENDAMUSTINE HYDROCHLORIDE: 25 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"16729-250"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=16729-250
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=33867f0f-f317-1fd0-e054-00144ff8d46c